Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Comment by MoriaDwarfon Nov 04, 2016 10:10pm
62 Views
Post# 25427158

RE:RE:RE:Impact of US elections

RE:RE:RE:Impact of US elections
MoriaDwarf wrote:
Saints4 wrote: If the election is on Tuesday. How could there be a 5-10 percent decrease on monday if the election hasn't happened yet?

Saints...
My reasoning is that many many Americans are currently, and have been for a while, scared shitless by the possibility of Trump winning... Fear in the market means De-risking, that means Selling. Monday is their last chance...
MDwarf



...48 minutes and 37 reads later...
Well, since nobody brought it up, I will add that my previous reasoning is at least partly flawed...
Since the markets are open Tuesday and the election results won't be known before Tuesday late at night, it follows that my 5-10%predicted decline my be spread over two days (Monday and Tuesday)... Furthermore some news content on Tuesday might damp or stoke the fire of Fear...
So, after all, guess is a guess, I guess...;-)

MDwarf
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities